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Most patients obtain medications from pharmacies by prescription, but rural general practices can 
dispense medications. Clinical implications of this difference in drug delivery are unknown. We 
hypothesised that dispensing status may be associated with better medication adherence. This could 
impact intermediate clinical outcomes dependent on medication adherence in, for example, 
hypertension or diabetes. 
Aim 
We investigated whether dispensing status is associated with differences in achievement of Quality 
and Outcome Framework (QOF) indicators that rely on medication adherence. 
Design and Setting 
Cross-sectional analysis of QOF data for 7,392 general practices in England. 
Method 
We analysed QOF data from 2016/17 linked to dispensing status for general practices with list sizes 
≥1000 in England. QOF indicators were categorised according to whether their achievement 
depended on a record of prescribing only, medication adherence, or neither. 
We estimated differences between dispensing and non-dispensing practices using mixed-effects 
logistic regression adjusting for practice population age, sex, deprivation, list size, single-handed 
status and rurality.  
Results  
Data existed for 7,392 practices; 1,014 (13.7%) could dispense. Achievement was better in 
dispensing practices than in non-dispensing practices for seven of nine QOF indicators dependant on 
adherence, including blood pressure targets. Only one of ten indicators dependent on prescribing 
but not adherence displayed evidence of a difference; indicators unrelated to prescribing showed a 
trend towards higher achievement by dispensing practices. 
Conclusion 
Dispensing practices may achieve better clinical outcomes than prescribing practices. Further work is 
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How this fits in 
• Around 15% of prescriptions given out by general practitioners do not get dispensed by 
pharmacies. 
 
• In dispensing general practices, medications are usually dispensed, as opposed to 
prescriptions being issued to patients. 
 
• We hypothesised that this organisational difference may promote greater medication 
adherence for patients of dispensing practices by streamlining the issuing of medications. 
 
• We studied Quality and Outcome Framework indicators and found higher achievement 
levels of blood pressure, and other targets, for dispensing than for non-dispensing practices.  
Further study is required to establish the mechanisms contributing to these findings. 
 
Clinical impact 
Dispensing practices show greater achievement of QOF targets dependent on medication adherence 
than non-dispensing practices.  




In some countries medications are both dispensed in pharmacies and issued directly to 
patients at primary care sites. United Kingdom (UK) general practices can hold contractual 
rights to dispense medication to patients who live more than 1 mile (1.6 km) from the 
nearest registered pharmacy. 1-3  Such dispensing practices are predominantly rural, where 
geographical barriers to alternative sources of medication and health care co-exist.4  Both 
rurality, and general practitioners’ (GPs) dispensing of medications may affect quality of 
care and health outcomes.5 Demographically, rural populations have slightly higher life 
expectancy, with higher proportions of elderly in comparison to urban areas.6 7 Dispensing 
practices are less likely to be single handed,8 and have shorter opening times than 
pharmacies. Historically, trained dispensers have run primary care dispensaries, however 
pharmacists are increasingly becoming integrated members of the primary health care team 
in all types of practices.9 10 In dispensing practice patient records of allergies and co-
morbidities are fully accessible to pharmacists and dispensers.10 Importantly, patients of 
dispensing practices can leave in possession of their prescribed medication, whereas in 
prescribing practices they leave with a prescription for dispensing elsewhere by a registered 
pharmacy. This raises the hypothesis that adherence to prescribed medications may be 
greater for patients of dispensing practices in comparison to non-dispensing practices, by 
virtue of streamlined access to medications. 
Non-adherence to prescription medication is a major cause of non-response to treatment. 
Between 11% and 19% of prescriptions are not actually dispensed to the patient, and 
barriers to medication possession exist at patient, doctor, and healthcare system levels.11 
Easy access to on-site pharmacy services may improve medication uptake and 
adherence,12,13 overcoming logistical barriers that keep patients from presenting their 
prescriptions elsewhere.14 These barriers are reduced or absent when patients attend 
dispensing practices. Patients’ medication beliefs,15 and concerns about taking 
medication,16-18 also play a role in medication adherence. A collaborative patient-physician 
relationship may be key to achieving positive beliefs about treatment and increasing 
adherence.19,20 incorporating the act of, or discussion of, dispensing into consultations may 
modify patients’ beliefs, since patients report higher levels of trust in their GPs than in 
community pharmacists.21 Furthermore, GPs are more likely to be aware of patients’ 
personal and medical circumstances than pharmacists, therefore they may better tailor their 
information to patients’ needs, taking account of issues such as health literacy.22,23  
Reduced logistical barriers, opportunities to address patients’ beliefs and tailoring of 
information to the patients’ needs may thus all influence medication adherence. However, 
no research has yet investigated how the dispensing status of practices may impact clinical 
outcomes dependent on good medication adherence. We hypothesised that on-site 
dispensing of medication may overcome some barriers to medication possession in 
comparison to the giving of a prescription. Medication adherence is not systematically 
recorded in primary care, but National Health Service (NHS) Quality and Outcome 
Framework (QOF) indicators are. QOF indicators include some measures of intermediate 
outcomes whose achievement is dependent on medication adherence, others where 
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achievement reflects prescribing irrespective of adherence, and a third group where 
achievement is unrelated to prescribing. Therefore we investigated how dispensing 
practices differ from non-dispensing practices in demographic profile, and sought to 
establish whether dispensing status is independently associated with better clinical 
outcomes, defined as higher achievement of QOF indicators that depend on medication 








Study design and setting 
We undertook cross-sectional analyses of QOF clinical indicator data from 2016/17, 
obtained from NHS Digital and linked it to Dispensing Practice data from March 2017, 
obtained from the NHS Business Services Authority. Data from March 2017 on practice 
population age, sex, practice list size, practice deprivation and workforce were also obtained 
from NHS Digital.24,25 Practices were classified as rural or urban using Office for National 
Statistic classification based on the postcodes.26 Datasets were linked to QOF and dispensing 
status using practice codes. All data are in the public domain thus no ethical approval was 
required. 
Outcome measures 
We classified QOF performance indicators into three groups according to their relation to 
prescribing: Group 1 were dependent on medication adherence, requiring the taking of a 
medication, for example indicators reporting percentages of patients meeting pre-specified 
blood pressure targets; Group 2 were achieved by evidence of prescription of a medication 
(regardless of adherence), for example indicators reporting percentage of patients with 
coronary heart disease with a record of antiplatelet or anticoagulant prescribing within the 
preceding year). The remaining QOF indicators were unrelated to specific medications 
(Group 3), for example the percentage of patients with stroke referred for further 
investigation. Group classification of indicators was achieved through consensus by 
discussion between three authors (MG-C, GA and CEC). 
Given organisational differences in the processes of obtaining medication between 
dispensing and non-dispensing practices, and our hypothesis that these differences may 
affect medication adherence, we expected greater achievement of indicators in group 1 by 
dispensing practices compared to non-dispensing practices, whilst indicators from group 2 
to should show no consistent differences. Thus group 2 represented a control set of 
indicators subject to any underlying trends according to dispensing status except differences 
in medication adherence. Group 3 provided further information on any underlying trends. 
Statistical analysis 
The raw counts of eligible patients (i.e. all patients fitting the corresponding indicator 
criterion, including those reported as exceptions) and of patients achieving each indicator in 
the QOF data, were used. QOF business rules allow doctors to report as exceptions certain 
patients from any indicator so that practices are not penalised financially for inappropriate 
reasons. Raw figures include any patients subsequently excluded through the exception 
reporting process. Thus raw data overcome any risk of bias due to variation in rates of 
exception reporting between practices. Similarly, missing data were not an issue since all 
people on a disease register were included in the denominator whether or not they had the 
appropriate outcome recorded. 
For each indicator we fitted unadjusted and adjusted mixed-effects grouped logistic 
regression models with numbers of patients at each practice achieving the indicator as 
numerator and the number of eligible patients at each practice as denominator.  Type of 
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practice (dispensing/not dispensing) was included as a fixed effect with practice as random 
effects. Adjusted models included the following practice level population characteristics: 
percentage of practice population aged ≥65, sex distribution, practice deprivation score, list 









Data existed for 7,392 practices and 1,014 (13.7%) had dispensing status. Dispensing 
practices had more patients aged ≥65, fewer deprived patients, were less often single-
handed, were more often rurally located, and had slightly larger list sizes when compared 
with non-dispensing practices (Table 1).  
Group 1: prescribing indicators dependent on adherence 
In adjusted and unadjusted models, the odds ratio (OR) for association with dispensing 
status was greater than one for all nine indicators, indicating higher achievement in 
dispensing practices. In unadjusted analyses, this only failed to reach significance for one 
indicator: percentage of patients with diabetes having total cholesterol ≤ 5 mmol/L (OR 
1.01, (95% confidence interval (CI) 0.99 to 1.03; P = 0.22; Table 2).  
After adjustment there were minor changes in ORs for most indicators. Substantial 
attenuation of differences in achievement for the three indicators related to HbA1c levels 
was observed; two of these had P-values > 0.05: percentage of patients with diabetes whose 
last HbA1c was ≤ 59 mmol/mol (OR 1.01 (0.98 to 1.03); P = 0.57) and ≤ 64 mmol/mol (OR 
1.02 (0.99 to 1.04); P = 0.22). For the remaining seven indicators, achievement was greater 
for dispensing practices than non-dispensing practices. These included blood pressure 
targets in hypertension, coronary heart disease, peripheral arterial disease, cerebrovascular 
disease and diabetes, achievement of diabetes targets for cholesterol lowering and for the 
highest threshold (≤75 mmol/mol) for HbA1c (Table 2; Figure 1).  
Group 2: prescribing indicators independent of adherence 
In contrast to group 1, unadjusted ORs for the ten prescribing indicators independent of 
adherence showed no consistency in direction. Only two indicators had ORs >1 indicating 
with half of the differences showing lower achievement (P<0.05). After adjustment the 
range of ORs was narrower and largely non-discriminatory; we only observed one 
statistically significant difference between dispensing and non-dispensing practice: the 
percentage of patients with atrial fibrillation being prescribed anticoagulants (OR 1.06 (1.03 
to 1.10); P < 0.001; Table 3, Figure 2). 
Group 3: prescribing indicators unrelated to medication 
There were 27 further QOF indicators not included in the above analyses. ORs in the 
adjusted analyses showed an overall trend towards higher achievement by dispensing 
practices (only three ORs being <1); ORs were significantly >1 for 13 (48%) indicators and < 1 









To our knowledge, this is the first study to consider the impact of primary care dispensing 
status on differential achievement of QOF indicators for chronic conditions. We found 
evidence for greater achievement by dispensing practices for seven of the nine QOF 
indicators that depend on adherence to medications. In contrast, a difference according to 
dispensing status was only observed in one of ten indicators dependent on prescribing but 
not adherence. Where indicator achievements were unrelated to prescribing, almost half of 
them were better achieved in dispensing practices. These findings are based on analysis of 
primary care data for England; they are directly relevant to other UK health services, as well 
as to other countries where access to medications is co-located with primary health care 
settings.  
Strengths and limitations 
This large study analysed data covering over 7,000 practices in England and is thus 
representative of the country and of the UK. We examined the full set of current QOF 
clinical indicators in unadjusted and adjusted models. We have previously observed the 
impact of exception reporting on net achievement of QOF indicators, therefore we only 
analysed raw achievement rates to avoid potential bias due to differences in exception 
reporting.9,28  
This practice-level observational analysis of routine data did not include any direct measures 
of individual medication adherence, only intermediate outcomes known to depend on good 
adherence. Medication adherence is affected by individual as well as organisational factors 
and we cannot be sure that our findings reflect impacts on individuals. The observed trends 
towards greater achievement in dispensing practices of QOF indicators unrelated to 
prescribing (group 3), suggest that other organisational characteristics of dispensing 
practices such as continuity of care, which could not be adjusted for in our analyses, may 
also be important.29 Residual confounding due to this, and other unknown and/or 
unadjusted factors, is highly likely to be implicated in our findings.30 Therefore we do not 
interpret these findings as clear evidence of differences in medication adherence rates 
according to practice dispensing status. The results are, however, consistent with our 
hypothesis that leaving a consultation with a medication, rather than with a prescription 
which may or may not be dispensed, removes one barrier to medication possession and 
therefore may plausibly affect medication adherence. 
Comparison with existing literature  
Practice characteristics previously associated with greater achievement of QOF indicators in 
Scotland have included higher deprivation levels, lower income from non NHS sources, 
younger ages of GPs and larger sizes of practice teams.31 The rural workforce tends to be 
older;32 we found lower rates of deprivation and single handed status amongst dispensing 
practices in the current study, therefore lower rather than higher underlying achievement of 
QOF indicators might have been predicted in dispensing practices, however no trend in 
either direction was evident from our control indicators, whilst adherence indicators 
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uniformly showed higher achievement with dispensing. Evidence relating deprivation to 
QOF achievement is mixed; associations are weak in magnitude, and complex in nature 
when other barriers to access for the most disadvantaged are accounted for.28,33,34 It has 
also been observed that generic indices of deprivation cannot reflect true levels of 
deprivation in rural areas due to wide heterogeneity of deprivation within such settings.35 
Our findings cannot readily be explained by any systematic differences in quality of care 
between dispensing and non-dispensing practices, although the trend to higher 
achievement of indicators unrelated to prescribing suggests that there may be underlying 
characteristics of dispensing practices, their patients, or both, contributing to these complex 
outcomes. Remoteness from urban centres, strongly correlated with dispensing status, does 
not correlate to a range of measures of quality of care.36 Historically dispensing practice has 
been associated with lower generic prescribing rates and higher drug unit costs than non-
dispensing practice.37,38 We found no evidence for higher rates of prescribing per se in 
association with dispensing status, thus the “perverse incentive” (now largely mitigated 
against anyway within the current GP contract) does not account for our findings either. It 
follows from our hypothesis that dispensing practice drug costs overall will appear to be 
higher due to improved medication collection alone, in comparison with non-dispensing 
practices. In fact, by demonstrating greater achievement of targets for intermediate 
outcomes such as blood pressure, fewer cardiovascular events and deaths might be 
predicted. Therefore to consider drug costs of dispensing practices in isolation, without 
health economic assessment inclusive of outcomes is potentially misleading.38,39  
Estimates of proportions of prescriptions issued but not dispensed vary widely; the median 
rate is around 15%.11,40 On-site provision of medication is a distinguishing feature of 
dispensing practices. Co-location of pharmacies within care settings can improve medication 
uptake and adherence,13 and logistical barriers to medication possession are lower where 
prescriptions can be dispensed on site or within easy geographical proximity.14 Despite 
adjusting our findings for recognised co-variates of QOF outcomes we recognise that 
residual confounding was possible. However, our findings seem consistent with the 
hypothesis that dispensing practices achieve higher rates of medication adherence due to 
greater ease of access. 
Implications for research and/or practice  
Although barriers to integration of community pharmacy services with primary care exist,41 
pharmacist engagement in primary care is rising, with roles beyond medication advice, 
increasingly including elements of direct patient care.9,42 Pharmacist led care can improve 
medication adherence in long-term conditions such as hypertension,43,44 and such 
interventions are cost and time saving for GPs.45,46 Community pharmacies are being 
increasingly co-located with, and/or managed by, primary care teams. Such proximity 
should facilitate medication adherence. This trend might lead to erosion, in time, of the 
differences in QOF achievement that we have observed here. The impact of financial 
incentives on achievement of these quality indicators is also important and may confound 
time-dependent trends in differences in medication adherence.47 We have not found any 
evidence addressing the impact of expanding numbers of pharmacies co-located with 
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surgeries on outcomes such as adherence. Further research on this topic could provide new 
insights into the importance of ready access to medications, irrespective of the right to 
dispense medications. 
Conclusions  
Dispensing directly to patients removes one barrier to medication possession in comparison 
to prescribing alone. Our findings offer initial evidence that dispensing of drugs may result in 
better intermediate clinical outcomes, as assessed by a range of QOF indicators, in 
comparison to prescribing alone. A range of organisational and individual factors, which we 
could not adjust for, may well contribute to our observations. The findings are consistent 
with our hypothesis that differences may be mediated through improved medication 
adherence, however we were unable to directly measure adherence. Further work is 
required to clarify the possible underlying mechanisms for and significance of these 
observations, incorporating adherence measures, and to assess the implications for other 
models of primary care dispensing such as on-site pharmacies. 
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Legends for tables and figures 
 
Table 1 - Characteristics of dispensing and non-dispensing practices in England 
Table 2 - Associations of group 1 outcomes – those dependent on medication adherence 
with dispensing status 
Table 3 - Associations of group 2 outcomes - those independent of medication adherence 
with dispensing status 
 
Figure 1 - Differences (OR) between dispensing and non-dispensing practices in outcomes 
dependent on adherence to medication 
Figure 2 – Differences (OR) between dispensing and non-dispensing practices in outcomes 
dependent on prescription but not adherence 
 


















Age over 65 sample median % (IQR) 23.7 (20.9 – 26.9) 16.2 (11.3 – 20.3) 17.3 (12.2 – 21.6) 
Males sample median % (IQR) 49.4 (48.8 – 50.0) 49.8 (48.9 – 51.1) 49.7 (48.9 – 50.9) 
Single-handed practices N (%) 28 (2.8) 476 (7.5) 504 (6.8) 
IMD least deprived N (%) 424 (42.4) 1,004 (16.4) 1,420 (20.0) 
Rural N (%) 717 (70.7) 375 (5.9) 1,092 (14.8) 
List size median (IQR) 7,016 (4,538 – 10,558) 6,795 (4,200 – 10,096) 6,825 (4,245 – 10,169) 















 Dispensing Not dispensing Unadjusted Adjusted 
Code Indicator Median % (IQR) Median % (IQR) OR (CI) P-value OR (CI) P- value 
CHD002 
Percentage of patients with 
coronary heart disease 
whose last blood pressure 
is ≤ 150/90 mmHg 
90.5 (87.6-92.7) 90.1 (86.4, 92.8) 1.08 (1.04, 1.12) < 0.001 1.10 (1.05, 1.15) < 0.001 
HYP006 
Percentage of patients with 
hypertension whose last 
blood pressure is 
≤ 150/90 mmHg 
82.2(78.6,85.2) 80.5 (76.9, 83.7) 1.12 (1.09, 1.15) < 0.001 1.07 (1.04, 1.11) < 0.001 
PAD002 
Percentage of patients with 
peripheral arterial disease 
whose last blood pressure 
is ≤ 150/90 mmHg 
88.2 (83.6,  92.0) 88.2 (82.5,  92.7) 1.06 (1.02, 1.11) 0.008 1.11 (1.05, 1.17) < 0.001 
STIA003 
Percentage of patients with 
a history of stroke or 
transient ischaemic attack 
whose last blood pressure 
is ≤ 150/90 mmHg 
85.8 (82.3, 89.1) 85.1 (80.8, 88.9) 1.07 (1.04, 1.10) < 0.001 1.07 (1.03, 1.11) 0.001 
DM002 
Percentage of patients with 
diabetes whose last blood 
pressure  
is ≤ 150/90 mmHg 
88.7 (85.6, 91.6) 87.6 (83.8, 90.8) 1.12 (1.08, 1.15) < 0.001 1.10 (1.06, 1.15) < 0.001 
DM004 
Percentage of patients with 
diabetes whose last total 
cholesterol  
is ≤ 5 mmol/L 
70.3 (66.1, 73.6) 69.9 (65.6, 73.9) 1.01 (0.99, 1.03) 0.22 1.03 (1.00, 1.06) 0.035 
DM007 
Percentage of patients with 
diabetes whose last HbA1c 
is ≤ 59 mmol/mol 
64.3 (60.2,68.4) 61.6 (57.1, 66.1) 1.12 (1.10, 1.14) < 0.001 1.01 (0.98, 1.03) 0.57 
DM008 
Percentage of patients with 
diabetes whose last HbA1c 
is ≤ 64 mmol/mol 
72.8 (69.0, 76.3) 69.5 (65.0, 73.6) 1.18 (1.15, 1.20) < 0.001 1.02 (0.99, 1.04) 0.22 
DM009 
Percentage of patients with 
diabetes whose last HbA1c 
is ≤ 75 mmol/mol 
84.1 (80.9, 86.6) 80.3 (76.2, 83.8) 1.28 (1.25, 1.31) < 0.001 1.04 (1.01, 1.08) 0.003 









  Dispensing Not dispensing Unadjusted Adjusted 
 Indicator Median % (IQR) Median % (IQR) OR (CI) P-value OR (CI) P-value 
AF007 
 
Percentage of patients with 
atrial fibrillation and 
CHA2DS2-VASc score ≥ 2 
treated with anti-
coagulants 




Percentage of patients with 
coronary heart disease 
prescribed anti-platelet 
agent or an anti-coagulant  
92.5 (90.2, 94.4) 92.7 (90.0, 94.8) 1.01  (0.97, 1.04) 0.75 1.07  (0.92, 1.24) 0.36 
HF003 
 
Percentage of patients with 
left ventricular systolic 
dysfunction prescribed an 
ACE-I or ARB  
84.8 (77.8, 91.7) 86.2 (78.3, 100) 0.95  (0.90, 0.99) 0.017 0.97  (0.92, 1.03) 0.34 
HF004 
 
Percentage of patients with 
left ventricular systolic 
dysfunction, treated with 
an ACE-I or ARB, also being 
prescribed a beta-blocker 
licensed for heart failure 




Percentage of patients with 
peripheral arterial disease 
prescribed aspirin or other 
antiplatelet agent  




Percentage of patients with 
non-haemorrhagic stroke 
or TIA prescribed 
antiplatelet agent or oral 
anti-coagulant 




Percentage of patients with 
diabetic nephropathy or 
micro-albuminuria, 
prescribed an ACE-I or ARB 




Percentage of patients with 
previous fragility fracture, 
and osteoporosis on DEXA 
scanning, prescribed a 
bone-sparing agent 




Percentage of patients with 
previous fragility fracture 
and osteoporosis 
prescribed a bone-sparing 
agent 




Percentage of patients 
newly diagnosed with 
hypertension, with QRISK2 
score ≥20%, prescribed a 
statin 
62.5 (50.0, 83.3) 75.0 (50.0, 100) 0.68  (0.63, 0.73) < 0.001 0.95  (0.87, 1.04) 0.26 




Figure 1 - Differences (OR) between dispensing and non-dispensing practices in outcomes dependent on adherence to medication 
 




Figure 2 – Differences (OR) between dispensing and non-dispensing practices in outcomes dependent on prescription but not adherence 
 
